Never Run Out Of Buyers To Sell To.
Transforming protein engineering on a global scale. Founded in 2020, Absea is one of the fastest-growing biotech companies, with over 250 employees worldwide. Our cutting-edge platform enables rapid development of soluble proteins and monoclonal antibodies, supporting up to new projects each month. In partnership with leaders in life sciences, we have built a synthetic library of soluble proteins, covering 70% of the human proteome, and we continue to expand our portfolio.Our validated monoclonal antibodies are designed for diverse applications and are ready for broad market supply. From our…
Annual Revenue$100M to $250M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.